These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20686876)

  • 1. Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.
    Andersen ES; Gerstoft J; Weis N
    Int J Hematol; 2010 Sep; 92(2):378-80. PubMed ID: 20686876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
    Simpson ND; Simpson PW; Ahmed AM; Nguyen MH; Garcia G; Keeffe EB; Ahmed A
    J Clin Gastroenterol; 2003 Jul; 37(1):68-71. PubMed ID: 12811213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B
    Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    Ahmed A; Keeffe EB
    Am J Gastroenterol; 1999 Jan; 94(1):249-51. PubMed ID: 9934765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.
    Lim LL; Wai CT; Lee YM; Kong HL; Lim R; Koay E; Lim SG
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1939-44. PubMed ID: 12390103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
    JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
    Mancuso A; Pagliaro L
    Am J Gastroenterol; 2002 May; 97(5):1268-9. PubMed ID: 12014746
    [No Abstract]   [Full Text] [Related]  

  • 8. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ; Yen CJ; Huang WT; Chen TY; Su WC; Tsao CJ
    Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab].
    Vives S; Sancho JM; Planas R; Ribera JM
    Med Clin (Barc); 2006 Jun; 127(1):39. PubMed ID: 16796944
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Tsutsumi Y; Tanaka J; Kawamura T; Miura T; Kanamori H; Obara S; Asaka M; Imamura M; Masauzi N
    Ann Hematol; 2004 Jan; 83(1):58-60. PubMed ID: 14513286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.
    Picardi M; Della Pepa R; Giordano C; Zacheo I; Pugliese N; Mortaruolo C; Trastulli F; Giordano A; Lucignano M; Di Perna M; Raimondo M; Salvatore C; Pane F
    Blood; 2019 Jan; 133(5):498-501. PubMed ID: 30530802
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
    Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy.
    Maguire CM; Crawford DH; Hourigan LF; Clouston AD; Walpole ET; Powell EE
    J Gastroenterol Hepatol; 1999 Aug; 14(8):801-3. PubMed ID: 10482432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
    Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
    Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
    Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
    Lee HJ; Kim DY; Keam B; Lee JH; Han SW; Oh DY; Yoon JH; Kim TY; Kim YJ; Lee KW; Kim JW; Jeong SH; Lee JS; Kim JH; Im SA
    Breast Cancer; 2014 Jul; 21(4):387-93. PubMed ID: 23073741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    Vassiliadis T; Garipidou V; Tziomalos K; Perifanis V; Giouleme O; Vakalopoulou S
    Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
    Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hepatitis B virus (HBV) infection on clinical outcomes of patients with diffuse large B-cell lymphoma.
    Law MF; Lai HK; Chan HN; Ha CY; Ng C; Yeung YM; Yip SF
    Eur J Cancer Care (Engl); 2015; 24(1):117-24. PubMed ID: 25848698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.